Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM 100

2,950.00p
   
  • Change Today:
    175.00p
  • 52 Week High: 4,500.00
  • 52 Week Low: 2,350.00
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 27,211
  • Market Cap: £154.13m
  • Beta: 0.01

Bioventix Overview

Bioventix was founded in 2003 as a biotechnology company specialising in the creation and supply of high-affinity sheep monoclonal antibodies (SMAs) for use in immunodiagnostics. However, the antibody technology laboratory and some of the staff have been based at the same location in Farnham, Surrey, UK since the early 1990s.

Key Personnel

CEO: Peter John Harrison
CFO: Bruce Hiscock
Chairman: Ian James Nicholson
Independent Non-Executive Director: Joanne (Jo) Pisani
Independent Non-Executive Director: Nicholas (Nick) John McCooke
Non-Executive Dir:

Contact Details

Address: 27-28 Eastcastle Street, London, United Kingdom, W1W 8DH
Website: http://www.bioventix.com

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-Share, FTSE AIM 100
ISIN: GB00B4QVDF07

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 2,950.00p
Change Today 175.00p
% Change 6.31 %
52 Week High 4,500.00
52 Week Low 2,350.00
Volume 27,211
Shares Issued 5.22m
Market Cap £154.13m
Beta 0.01

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
15.16% below the market average15.16% below the market average15.16% below the market average15.16% below the market average15.16% below the market average
48.94% above the sector average48.94% above the sector average48.94% above the sector average48.94% above the sector average48.94% above the sector average
Price Trend
63.16% below the market average63.16% below the market average63.16% below the market average63.16% below the market average63.16% below the market average
19.15% below the sector average19.15% below the sector average19.15% below the sector average19.15% below the sector average19.15% below the sector average
Income
43.99% above the market average43.99% above the market average43.99% above the market average43.99% above the market average43.99% above the market average
42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average42.86% above the sector average
Growth
17.21% below the market average17.21% below the market average17.21% below the market average17.21% below the market average17.21% below the market average
35.48% below the sector average35.48% below the sector average35.48% below the sector average35.48% below the sector average35.48% below the sector average

Bioventix Dividends

  Latest Previous
  1st Interim 2nd Interim
Ex-Div 10-Apr-25 07-Nov-24
Paid 25-Apr-25 21-Nov-24
Amount 70.00p 87.00p

Trades for 20-May-2025

Time Volume / Share Price
16:35 1,200 @ 2,882.00p
16:25 1,000 @ 2,918.00p
16:25 1,000 @ 2,918.00p
11:31 10,000 @ 2,850.00p
16:42 9,500 @ 2,895.79p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page